Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW was delisted on the 28th of April, 2023.
31 hedge funds and large institutions have $2.18M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
7% more funds holding
Funds holding: 29 → 31 (+2)
2% more capital invested
Capital invested by funds: $2.14M → $2.18M (+$39.6K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$16.2K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$15.1K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.99K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$194 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$4.33K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$3K |
ORIAW Hedge Fund Activity: Q3 2022 in Review
31 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Warrant (ORIAW) for Q3 2022, worth a combined $2.18M — up 1.8% from $2.14M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ORIAW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $16.2K. The largest seller was Kepos Capital, cutting an estimated $4.33K.
- 31 institutional investors held Orion Biotech Opportunities Corp. Warrant (ORIAW) as of Q3 2022, up from 29 in Q2 2022.
- Funds reported $2.18M of Orion Biotech Opportunities Corp. Warrant stock for Q3 2022, up 1.8% quarter-over-quarter.
- 3 funds opened new Orion Biotech Opportunities Corp. Warrant positions in Q3 2022 and 1 closed out, a net change of +2 holders.
- The largest Orion Biotech Opportunities Corp. Warrant buyer in Q3 2022 was Calamos Advisors, an estimated $16.2K added.
- The largest Orion Biotech Opportunities Corp. Warrant seller in Q3 2022 was Kepos Capital, an estimated $4.33K sold.
Based on aggregated 13F filings for Q3 2022.